this is getting interesting, page-8

I have been short BTA from $3.05 and still hold.

Swine Flu or H1N1 was a highly exaggerated virus, one which was nowhere near as dangerous as the media or drug companies want us to believe.

Seasonal Flu is still much more of a worry than swine flu and has a much higher mortality rate.

I'm no expert on BTA, I'm sure they have much more going for them than Relenza.

My decision to be short was based on my view that Relenza and Tamiflu will both fail.

BTA's rise has mostly been on the back of Relenza so their drop will be based on the same I feel.

If the decline in BTA continues, I would not be surprised to see it find support at $1.25 although I will have covered by then.

Here is some interesting info on swine flu -

http://www.youtube.com/watch?v=rCadkv_8_5Q